Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Christopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.

Professor Christopher Buckley

The prize, awarded by the Hessian State Capital Wiesbaden, Germany, is based on outstanding innovate research activities in the field of rheumatology. This prestigious award is the highest international honour a rheumatologist can receive; Professor Buckley shares this year's award with Professor Dirk Elewaut from Ghent University.

Professor Buckley directs the Arthritis Therapy Acceleration Programme (A-TAP), an initiative led by the Universities of Oxford and Birmingham, which is funded by the Kennedy Trust for Rheumatology Research, and is supported by the NIHR Birmingham Biomedical Research Centre.

A-TAP aims to deliver 'stratified pathology; the right drug for the right disease indication' in a range of immune mediated inflammatory diseases.

Professor Buckley is only the sixth rheumatologist in the UK to have been awarded the prize since it was established in 1972. To recognise the outstanding research results and his remarkable contributions to rheumatology, a presentation ceremony for the prize will take place in May 2021, delayed this year due to the current coronavirus pandemic.

Speaking of his award, Professor Buckley said: "It is a real honor to have been awarded the Carol Nachman prize to recognise the value of team based science, that crosses not only from the bench to beside, but bedside to bedside (across medical disciplines) as well as universities. My discovery science and clinical colleagues in both Oxford and Birmingham as well as the seven NHS hospitals that are affiliated with A-TAP are such amazing people to work with and I owe them a debt of gratitude for supporting the A-TAP vision."

Professor Fiona Powrie, Director of the Kennedy Institute at the University of Oxford said: "Many congratulations to Chris on receiving this prestigious international award recognising his pioneering work on the pathogenesis of rheumatoid arthritis and the search for new therapies."

Professor Janet Lord, Director of the Institute of Inflammation and Ageing at the University of Birmingham, added: "This award is a fitting recognition of Professor Buckley's outstanding contribution to understanding the pathology of Rheumatoid Arthritis. Importantly, through A-TAP, he is now deploying this knowledge to develop improved therapies for this debilitating disease"

Professor Stephen Holgate, Chair of the Kennedy Trust for Rheumatology Research said: "This prestigious Prize is a fitting tribute to Professor Buckley, who's vision and drive have made the A-TAP initiative such a success. The Kennedy Trust is delighted to have been able to support his work and offer him our warmest congratulations."

Similar stories

New children’s orthopaedic hospital opens in Zimbabwe

Main

A new children’s orthopaedic hospital in Bulawayo that will treat children across Zimbabwe who are living with musculoskeletal impairments has opened today.

Professor Katja Simon elected to the Academy of Medical Sciences

Awards Kennedy Main

Professor of Immunology Katja Simon has been elected as a Fellow of the Academy of Medical Sciences.

3,400 different medicines used globally to treat COVID-19

Main Statistics and epidemiology

Insufficient data, and misleading recommendations led to significant early heterogeneity in global COVID-19 patient management, according to recent BMJ study

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.